These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9213289)

  • 21. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V; Fehér L
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):19-25. PubMed ID: 15125310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia with impulsive and aggressive behaviors.
    Lindenmayer JP; Kanellopoulou I
    Psychiatr Clin North Am; 2009 Dec; 32(4):885-902. PubMed ID: 19944890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials.
    Aleman A; Kahn RS
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):289-93. PubMed ID: 11532383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis.
    Zarcone JR; Lindauer SE; Morse PS; Crosland KA; Valdovinos MG; McKerchar TL; Matthew Reese R; Hellings JA; Schroeder SR
    Am J Ment Retard; 2004 Jul; 109(4):310-21. PubMed ID: 15176916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological soft signs and response to risperidone in chronic schizophrenia.
    Smith RC; Kadewari RP
    Biol Psychiatry; 1996 Nov; 40(10):1056-9. PubMed ID: 8915566
    [No Abstract]   [Full Text] [Related]  

  • 26. Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia.
    Cai HL; Zhu RH; Li HD; Zhang XH; Hu L; Yang W; Ye HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1273-8. PubMed ID: 20637820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of risperidone on seclusion and restraint at a state psychiatric hospital.
    Chengappa KN; Levine J; Ulrich R; Parepally H; Brar JS; Atzert R; Brienzo R; Gopalani A
    Can J Psychiatry; 2000 Nov; 45(9):827-32. PubMed ID: 11143833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):161-2. PubMed ID: 11285097
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.
    Pasini A; D'Agati E; Casarelli L; Curatolo P
    Brain Dev; 2010 May; 32(5):425-7. PubMed ID: 19428206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based psychopharmacology 2. Appraising a systematic review: is risperidone better than conventional antipsychotics in the treatment of schizophrenia?
    Warner JP
    J Psychopharmacol; 1999 Dec; 13(4):415-8. PubMed ID: 10667619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium.
    Comai S; Tau M; Pavlovic Z; Gobbi G
    J Clin Psychopharmacol; 2012 Apr; 32(2):237-60. PubMed ID: 22367663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of violence in schizophrenia and implications for long-term treatment.
    Volavka J; Citrome L
    Int J Clin Pract; 2008 Aug; 62(8):1237-45. PubMed ID: 18564202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of risperidone in treatment-resistant schizophrenia: two case reports.
    Warner JP; Gledhill JA; Wakeling A
    Int Clin Psychopharmacol; 1996 Mar; 11(1):65-6. PubMed ID: 8732318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risperidone treatment for polydipsia and severe hyponatremia in a schizophrenic patient].
    Chhoumi M; Mrad A; Mechri A
    Therapie; 2015; 70(3):309-10. PubMed ID: 25487849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical procedure with aggressive patients: experiences of psychiatric clinic in Wroclaw].
    Kiejna A; Jańska-Skomorowska M; Baranowski P
    Psychiatr Pol; 1993; 27(5):501-13. PubMed ID: 7902991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone].
    Hässler F; Buchmann J; Bohne S
    Nervenarzt; 2002 Mar; 73(3):278-82. PubMed ID: 11963264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the effective psychiatric spectrum of some antipsychotics].
    Ding QZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):306-10, 320. PubMed ID: 2906859
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of psychogenic polydipsia with risperidone in two children diagnosed with schizophrenia.
    Dogangün B; Hergüner S; Atar M; Kara B; Aksoy MU; Kayaalp L; Tüzün U
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):492-5. PubMed ID: 16958574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.